Epi-Phare company information, Employees & Contact Information

Social and Regional Inequalities in Maternal Respiratory Syncytial Virus Vaccination in France epi-phare

Real-world efficacy and safety of trastuzumab deruxtecan epi-phare

Nirsevimab Effectiveness at Preventing RSV-Related Hospitalization in Infants epi-phare

COVID-19 vaccination determinants in children aged 5–11 years epi-phare

Trastuzumab deruxtecan in HER2-positive and HER2-low metastatic breast cancer epi-phare

Use of Semaglutide (Wegovy) in Adults in France epi-phare

Chlormadinone acetate and risk of intracranial meningioma epi-phare

Award from the American Heart Association epi-phare

Use of progestogens and the risk of intracranial meningioma epi-phare

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines epi-phare

Trastuzumab Deruxtecan in Metastatic Gastric Cancer epi-phare

PrEP uptake among MSM in France epi-phare

Suivi de l’utilisation de Truvada® ou génériques epi-phare

Risk of heavy menstrual bleeding following COVID-19 vaccination epi-phare

Real-world effectiveness of HIV pre-exposure prophylaxis epi-phare

Roll-out of HIV pre-exposure prophylaxis use in France epi-phare

mRNA Covid-19 vaccine dosing interval and the risk of myocarditis epi-phare

Medically Assisted Reproduction and Risk of Cancer Among Offspring epi-phare

Use of the French National Health Data System (SNDS) in pharmacoepidemiology epi-phare

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe Covid-19 epi-phare

COVID-19 Hospitalization in Solid Organ Transplant Recipients epi-phare

Antibiotic exposure during pregnancy epi-phare

Second-line biologics in psoriasis after first-line biologic failure epi-phare

Use of mycophenolate epi-phare

Finasteride and suicidal risk epi-phare

Hydroxychloroquine or chloroquine and risk of hospitalisation for Covid-19 epi-phare

Levonorgestrel Intrauterine Systems and Use of Psychotropic Drugs epi-phare

Antiepileptic drugs during pregnancy and neurodevelopmental outcomes epi-phare

A modified SCCS method with application to COVID-19 vaccine safety epi-phare

Proton Pump Inhibitors and Upper Gastrointestinal Bleeding epi-phare

Médicaments potentiellement inappropriés chez les personnes âgées epi-phare

mRNA vaccine effectiveness against Covid-19 in elderly people epi-phare

New publication in Alimentary Pharmacologiy & Therapeutics epi-phare

Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe. epi-phare

Risk factors for Covid hospitalisation after booster vaccination during Omicron epi-phare

Drug use for gastrointestinal symptoms during pregnancy epi-phare

Biologics and risk of serious infection in Patients with psoriasis epi-phare

Interleukin 17 inhibitors: Risk of inflammatory bowel disease epi-phare

Paclitaxel stents and balloons epi-phare

Vaccination obligatoire et épidémie de Covid-19 epi-phare

Proton Pump Inhibitors and Risk of Pancreatic Cancer epi-phare

Grossesse et maladie inflammatoire de l’intestin epi-phare

Facteurs de risques d’hospitalisation et de décès à l’hôpital pour Covid-19 epi-phare

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis epi-phare

Impact of Levothyrox formulation change on health and healthcare use in France epi-phare

Médicaments des MICI et issues de grossesse epi-phare

Profiles of copper IUD and levonorgestrel intrauterine systems users epi-phare

Utilisation intravitréenne d’anti-VEGF en France epi-phare

Exposure to Mycophenolic Acid Products during pregnancy from 2010 to 2017 in France epi-phare

Anti-VEGF : risque d’infarctus du myocarde, d’AVC ou de décès epi-phare

Utilisation de Beyfortus® en ville lors de la première campagne de prévention epi-phare

Utilisation prolongée de l’acétate de nomégestrol et risque de méningiome intracrânien epi-phare

Covid-19 : facteurs de risques hospitalisation décès - 2ème vague epi-phare

Acétate de cyprotérone : évaluation de l’impact des mesures de réduction du risque de méningiomes intracrâniens epi-phare

Covid-19 et initatiation des traitements psoriasis epi-phare

Chimiothérapie du cancer du sein et risque de cancers hématologiques secondaires epi-phare

PrEPP VIH : suivi de l’utilisation de Truvada® ou génériques epi-phare